-
2
-
-
26844538114
-
Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials
-
DOI 10.1001/jama.294.15.1934
-
Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294:1934-43. (Pubitemid 41464695)
-
(2005)
Journal of the American Medical Association
, vol.294
, Issue.15
, pp. 1934-1943
-
-
Schneider, L.S.1
Dagerman, K.S.2
Insel, P.3
-
3
-
-
85038456566
-
-
accessed 2011 Jun 14
-
The Food and Drug Administration. www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm094303.htm (accessed 2011 Jun 14).
-
-
-
-
4
-
-
85038478215
-
OIG report evaluates claims for atypical antipsychotic drugs prescribed to nursing home residents
-
Anonymous. May 20, accessed 2011 Jun 14
-
Anonymous. OIG report evaluates claims for atypical antipsychotic drugs prescribed to nursing home residents. Formulary News, May 20, 2011. http://formularyjournal.modernmedicine.com/formulary/articleDetail.jsp?id=7232 (accessed 2011 Jun 14).
-
(2011)
Formulary News
-
-
-
5
-
-
84860303736
-
Government reports wide misuse of antipsychotics
-
Steinke S. Government reports wide misuse of antipsychotics. Caring for the Ages 2011;12:1,8.
-
(2011)
Caring for the Ages
, vol.12
-
-
Steinke, S.1
-
7
-
-
33751561455
-
Dementia
-
Fausi AS, Kasper DL, Longo DL, et al., eds. 17th ed. New York: McGraw-Hill Medical
-
Bird TD, Miller BL. Dementia. In: Fausi AS, Kasper DL, Longo DL, et al., eds. Harrison's principles of internal medicine. 17th ed. New York: McGraw-Hill Medical, 2008:2536-49.
-
(2008)
Harrison's Principles of Internal Medicine
, pp. 2536-2549
-
-
Bird, T.D.1
Miller, B.L.2
-
8
-
-
84860297217
-
The ethics of antipsychotics in Alzheimer's
-
Evans J. The ethics of antipsychotics in Alzheimer's. Caring for the Ages 2011;12:27.
-
(2011)
Caring for the Ages
, vol.12
, pp. 27
-
-
Evans, J.1
-
9
-
-
33751012402
-
Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: A systematic review
-
DOI 10.1001/archinte.166.20.2182
-
Ayalon L, Gum AM, Feliciano L, Areán PA. Effectiveness of non-pharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review. Arch Intern Med 2006;166:2182-8. (Pubitemid 44748764)
-
(2006)
Archives of Internal Medicine
, vol.166
, Issue.20
, pp. 2182-2188
-
-
Ayalon, L.1
Gum, A.M.2
Feliciano, L.3
Arean, P.A.4
-
10
-
-
84860271117
-
Music therapy may help dementia patients especially
-
Harrison L. Music therapy may help dementia patients especially. Caring for the Ages 2011;12:1-2.
-
(2011)
Caring for the Ages
, vol.12
, pp. 1-2
-
-
Harrison, L.1
-
11
-
-
79953002348
-
Antidepressants for agitation and psychosis in dementia
-
Feb16:CD008191
-
Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P. Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev 2011;Feb16:CD008191.
-
(2011)
Cochrane Database Syst Rev
-
-
Seitz, D.P.1
Adunuri, N.2
Gill, S.S.3
Gruneir, A.4
Herrmann, N.5
Rochon, P.6
-
12
-
-
38949131833
-
Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: A literature review
-
DOI 10.1017/S1041610207006540, PII S1041610207006540
-
Konovalov S, Muralee S, Tampi RR. Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review. Int Psychogeriatr 2008;20:293-308. (Pubitemid 351230232)
-
(2008)
International Psychogeriatrics
, vol.20
, Issue.2
, pp. 293-308
-
-
Konovalov, S.1
Muralee, S.2
Tampi, R.R.3
-
13
-
-
84860302242
-
Alzheimer's disease
-
DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. 8th ed. New York: McGraw-Hill Medical
-
Slattum PW, Swerdlow RH, Hill AM. Alzheimer's disease. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy, a pathophysiologic approach. 8th ed. New York: McGraw-Hill Medical, 2011:958-60.
-
(2011)
Pharmacotherapy, A Pathophysiologic Approach
, pp. 958-960
-
-
Slattum, P.W.1
Swerdlow, R.H.2
Hill, A.M.3
-
14
-
-
39749114585
-
Management of the behavioral and psychological symptoms of dementia
-
Hersch EC, Falzgraf S. Management of the behavioral and psychological symptoms of dementia. Clin Interv Aging 2007;2:611-21.
-
(2007)
Clin Interv Aging
, vol.2
, pp. 611-621
-
-
Hersch, E.C.1
Falzgraf, S.2
-
15
-
-
0035107116
-
Recommendations for the management of behavioral and psychological symptoms of dementia
-
Herrmann N. Recommendations for the management of behavioral and psychological symptoms of dementia. Can J Neurol Sci 2001;28(suppl 1):S96-107.
-
(2001)
Can J Neurol Sci
, vol.28
, Issue.SUPPL. 1
-
-
Herrmann, N.1
-
16
-
-
0036436448
-
Risperidone (Risperdal). Increased rate of cerebrovascular events in dementia trials
-
Wooltorton E. Risperidone (Risperdal). Increased rate of cerebrovascular events in dementia trials. CMAJ 2002;167:11.
-
(2002)
CMAJ
, vol.167
, pp. 11
-
-
Wooltorton, E.1
-
17
-
-
0001478989
-
Drugs and the treatment of psychiatric disorders
-
Hardman JG, Limbird LE, eds. 10th ed. New York: McGraw Hill Medical
-
Baldessarini RJ, Tarazi FI. Drugs and the treatment of psychiatric disorders. In: Hardman JG, Limbird LE, eds. The pharmacological basis of therapeutics. 10th ed. New York: McGraw Hill Medical, 2001:487-91.
-
(2001)
The Pharmacological Basis of Therapeutics
, pp. 487-491
-
-
Baldessarini, R.J.1
Tarazi, F.I.2
-
18
-
-
77956200592
-
Drugs for psychotic disorders. Treatment guidelines
-
Anonymous
-
Anonymous. Drugs for psychotic disorders. Treatment guidelines. The Medical Letter 2010;8:61-4.
-
(2010)
The Medical Letter
, vol.8
, pp. 61-64
-
-
-
19
-
-
84863834986
-
Movement disorders
-
Tisdale JE, Miller DA, eds. 2nd ed. Bethesda, MD: ASHP
-
Chen JJ, Swope DM. Movement disorders. In: Tisdale JE, Miller DA, eds. Drug induced diseases. 2nd ed. Bethesda, MD: ASHP, 2010:213-8.
-
(2010)
Drug Induced Diseases
, pp. 213-218
-
-
Chen, J.J.1
Swope, D.M.2
-
20
-
-
0035286571
-
From Clinical Trials to Real-World Practice: Use of Atypical Antipsychotic Medication Nationally in the Department of Veterans Affairs
-
Rosenheck R, Leslie D, Sernyak M. From clinical trials to real-world practice: use of atypical antipsychotic medication nationally in the Department of Veterans Affairs. Med Care 2001;39:302-8. (Pubitemid 33694141)
-
(2001)
Medical Care
, vol.39
, Issue.3
, pp. 302-308
-
-
Rosenheck, R.1
Leslie, D.2
Sernyak, M.3
-
21
-
-
3142588866
-
Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: Systematic review
-
Lee PE, Gill SS, Freedman M, Bronskill SE, Hillmer MP, Rochon PA. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ 2004:329:75-9.
-
(2004)
BMJ
, vol.329
, pp. 75-79
-
-
Lee, P.E.1
Gill, S.S.2
Freedman, M.3
Bronskill, S.E.4
Hillmer, M.P.5
Rochon, P.A.6
-
22
-
-
33746884732
-
-
St. Louis, MO. Wolters Kluwer Health
-
Drug facts and comparisons. St. Louis, MO. Wolters Kluwer Health, 2011:933-9.
-
(2011)
Drug Facts and Comparisons
, pp. 933-939
-
-
-
23
-
-
0031756048
-
Efficacy and safety of neuroleptics in the behavioral disorders associated with dementia
-
Lanctot KL, Best TS, Mittmann N, et al. Efficacy and safety of neuroleptics in the behavioral disorders associated with dementia. J Clin Psychiatry 1998;59:550-1.
-
(1998)
J Clin Psychiatry
, vol.59
, pp. 550-551
-
-
Lanctot, K.L.1
Best, T.S.2
Mittmann, N.3
-
24
-
-
28244431743
-
Risk of death in elderly users of conventional vs. atypical antipsychotic medications
-
DOI 10.1056/NEJMoa052827
-
Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional versus atypical antipsychotic medications. N Engl J Med 2005;353:2335-41. (Pubitemid 41713745)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.22
, pp. 2335-2341
-
-
Wang, P.S.1
Schneeweiss, S.2
Avorn, J.3
Fischer, M.A.4
Mogun, H.5
Solomon, D.H.6
Brookhart, M.A.7
-
25
-
-
12844274439
-
Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence
-
DOI 10.1001/jama.293.5.596
-
Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005;293:596-608. (Pubitemid 40171242)
-
(2005)
Journal of the American Medical Association
, vol.293
, Issue.5
, pp. 596-608
-
-
Sink, K.M.1
Holden, K.F.2
Yaffe, K.3
-
26
-
-
77951761692
-
The elderly safety imperative and antipsychotic usage
-
Chahine LM, Acar D, Chemali Z. The elderly safety imperative and antipsychotic usage. Harv Rev Psychiatry 2010;18:158-72.
-
(2010)
Harv Rev Psychiatry
, vol.18
, pp. 158-172
-
-
Chahine, L.M.1
Acar, D.2
Chemali, Z.3
-
27
-
-
0032966714
-
Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial
-
Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry 1999;60:107-15. (Pubitemid 29104387)
-
(1999)
Journal of Clinical Psychiatry
, vol.60
, Issue.2
, pp. 107-115
-
-
Katz, I.R.1
Jeste, D.V.2
Mintzer, J.E.3
Clyde, C.4
Napolitano, J.5
Brecher, M.6
-
28
-
-
0033595555
-
A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia
-
DeDeyn PP, Rabheru K, Rasmussen A, et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 1999;53:946-55. (Pubitemid 29442108)
-
(1999)
Neurology
, vol.53
, Issue.5
, pp. 946-955
-
-
De Deyn, P.P.1
Rabheru, K.2
Rasmussen, A.3
Bocksberger, J.P.4
Dautzenberg, P.L.J.5
Eriksson, S.6
Lawlor, B.A.7
-
29
-
-
0037328229
-
A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia
-
Brodaty H, Ames D, Snowdon J, et al. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry 2003;64:134-43. (Pubitemid 36268315)
-
(2003)
Journal of Clinical Psychiatry
, vol.64
, Issue.2
, pp. 134-143
-
-
Brodaty, H.1
Ames, D.2
Snowdon, J.3
Woodward, M.4
Kirwan, J.5
Clarnette, R.6
Lee, E.7
Lyons, B.8
Grossman, F.9
-
30
-
-
33644885707
-
Risperidone in the treatment of psychosis of Alzheimer's disease: Results from a prospective clinical trial
-
Mintzer J, Greenspan A, Caers I. Risperidone in the treatment of psychosis of Alzheimer's disease: results from a prospective clinical trial. Am J Geriatr Psychiatry 2006;14:280-91.
-
(2006)
Am J Geriatr Psychiatry
, vol.14
, pp. 280-291
-
-
Mintzer, J.1
Greenspan, A.2
Caers, I.3
-
31
-
-
0033799993
-
Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer's disease in nursing care facilities: A double-blind, randomized, placebo-controlled trial
-
Street JS, Clark WS, Gannon KS, et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer's disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2000;57:968-76.
-
(2000)
Arch Gen Psychiatry
, vol.57
, pp. 968-976
-
-
Street, J.S.1
Clark, W.S.2
Gannon, K.S.3
-
32
-
-
1342347803
-
Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease
-
DOI 10.1002/gps.1032
-
DeDeyn PP, Carrasco MM, Deberdt W, et al. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease. Int J Geriatr Psychiatry 2004,19:115-26. (Pubitemid 38247846)
-
(2004)
International Journal of Geriatric Psychiatry
, vol.19
, Issue.2
, pp. 115-126
-
-
De Deyn, P.P.1
Carrasco, M.M.2
Deberdt, W.3
Jeandel, C.4
Hay, D.P.5
Feldman, P.D.6
Young, C.A.7
Lehman, D.L.8
Breier, A.9
-
33
-
-
23944487151
-
Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia
-
Deberdt WG, Dysken MW, Rappaport SA, et al. Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia. Am J Geriatr Psychiatry 2005;13:722-30.
-
(2005)
Am J Geriatr Psychiatry
, vol.13
, pp. 722-730
-
-
Deberdt, W.G.1
Dysken, M.W.2
Rappaport, S.A.3
-
34
-
-
25444518037
-
Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: A randomized, placebo-controlled study
-
DOI 10.1097/01.jcp.0000178415.22309.8f
-
DeDeyn PP, Jeste DV, Swanink R, et al. Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebo controlled study. J Clin Psychopharmacol 2005;25:463-7. (Pubitemid 41368369)
-
(2005)
Journal of Clinical Psychopharmacology
, vol.25
, Issue.5
, pp. 463-467
-
-
De Deyn, P.1
Jeste, D.V.2
Swanink, R.3
Kostic, D.4
Breder, C.5
-
35
-
-
33847132248
-
Quetiapine to treat agitation in dementia: A randomized, double-blind, placebo-controlled study
-
DOI 10.2174/156720507779939805
-
Zhong KX, Tariot PN, Mintzer J, Minkwitz MC, Devine NA. Quetiapine to treat agitation in dementia: a randomized double-blind placebo-controlled study. Curr Alzheimer Res 2007;4:81-93. (Pubitemid 46293886)
-
(2007)
Current Alzheimer Research
, vol.4
, Issue.1
, pp. 81-93
-
-
Zhong, K.X.1
Tariot, P.N.2
Mintzer, J.3
Minkwitz, M.C.4
Devine, N.A.5
-
36
-
-
47749146154
-
Antipsychotics for the treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)
-
DOI 10.2174/157015908784533860
-
Liperoti R, Pedone C, Corsonello A. Antipsychotics for the treatment of behavioral and psychological symptoms of dementia. Curr Neuropharmacol 2008;6:117-24. (Pubitemid 352024796)
-
(2008)
Current Neuropharmacology
, vol.6
, Issue.2
, pp. 117-124
-
-
Liperoti, R.1
Pedone, C.2
Corsonello, A.3
-
37
-
-
33748585223
-
Quetiapine treatment of psychosis associated with dementia: A double-blind, randomized, placebo-controlled clinical trial
-
DOI 10.1097/01.JGP.0000196628.12010.35
-
Tariot PN, Schneider L, Katz IR, et al. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial. Am J Geriatr Psychiatry 2006;14:767-76. (Pubitemid 44380069)
-
(2006)
American Journal of Geriatric Psychiatry
, vol.14
, Issue.9
, pp. 767-776
-
-
Tariot, P.N.1
Schneider, L.2
Katz, I.R.3
Mintzer, J.E.4
Street, J.5
Copenhaver, M.6
Williams-Hughes, C.7
-
38
-
-
46749095495
-
Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: Phase 1 outcomes from the CATIE-AD effectiveness trial
-
DOI 10.1176/appi.ajp.2008.07111779
-
Sultzer DL, Davis SM, Tariot PN, et al. Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry 2008;165:844-54. (Pubitemid 351948716)
-
(2008)
American Journal of Psychiatry
, vol.165
, Issue.7
, pp. 844-854
-
-
Sultzer, D.L.1
Davis, S.M.2
Tariot, P.N.3
Dagerman, K.S.4
Lebowitz, B.D.5
Lyketsos, C.G.6
Rosenheck, R.A.7
Hsiao, J.K.8
Lieberman, J.A.9
Schneider, L.S.10
-
39
-
-
77956625354
-
Swedish clinical guidelines-prevention and management of metabolic risk in patients with severe psychiatric disorders
-
Gothefors D, Adolfsson R, Attvall S, et al. Swedish clinical guidelines-prevention and management of metabolic risk in patients with severe psychiatric disorders. Nord J Psychiatry 2010;64:294-302.
-
(2010)
Nord J Psychiatry
, vol.64
, pp. 294-302
-
-
Gothefors, D.1
Adolfsson, R.2
Attvall, S.3
-
40
-
-
56849102843
-
Metabolic syndrome and atypical antipsychotics: A selective literature review
-
Kannabrian M, Singh V. Metabolic syndrome and atypical antipsychotics: a selective literature review. German J Psychiatry 2008;11:111-22.
-
(2008)
German J Psychiatry
, vol.11
, pp. 111-122
-
-
Kannabrian, M.1
Singh, V.2
-
41
-
-
4644354707
-
Atypical antipsychotics and metabolic disregulation: Evaluating the risk/benefit equation and improving the standard of care
-
Nasrallah HA, Newcomer JW. Atypical antipsychotics and metabolic disregulation: evaluating the risk/benefit equation and improving the standard of care. J Clin Psychopharmacol 2004;24(suppl 1):S7-14.
-
(2004)
J Clin Psychopharmacol
, vol.24
, Issue.SUPPL. 1
-
-
Nasrallah, H.A.1
Newcomer, J.W.2
-
42
-
-
0034042934
-
Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study
-
DOI 10.1176/appi.ajp.157.6.975
-
Henderson DC, Cagliero E, Gray C, et al. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. Am J Psychiatry 2000;157:975-81. (Pubitemid 30412350)
-
(2000)
American Journal of Psychiatry
, vol.157
, Issue.6
, pp. 975-981
-
-
Henderson, D.C.1
Cagliero, E.2
Gray, C.3
Nasrallah, R.A.4
Hayden, D.L.5
Schoenfeld, D.A.6
Goff, D.C.7
-
43
-
-
0036213607
-
Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia
-
DOI 10.1176/appi.ajp.159.4.561
-
Sernyak MJ, Leslie DL, Alarcon RD, et al. Association of diabetes mellitus with the use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry 2002;159:561-6. (Pubitemid 34274937)
-
(2002)
American Journal of Psychiatry
, vol.159
, Issue.4
, pp. 561-566
-
-
Sernyak, M.J.1
Leslie, D.L.2
Alarcon, R.D.3
Losonczy, M.F.4
Rosenheck, R.5
-
44
-
-
2942618528
-
Atypical antipsychotics and risk of cerebrovascular accidents
-
DOI 10.1176/appi.ajp.161.6.1113
-
Herrmann N, Mamdani M, Lanctôt KL. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 2004;161:1113-5. (Pubitemid 38736000)
-
(2004)
American Journal of Psychiatry
, vol.161
, Issue.6
, pp. 1113-1115
-
-
Herrmann, N.1
Mamdani, M.2
Lanctot, K.L.3
-
45
-
-
77957171407
-
Antipsychotic drugs and risk of venous thromboembolism: Nested case-control study
-
Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ 2010;341:4245.
-
(2010)
BMJ
, vol.341
, pp. 4245
-
-
Parker, C.1
Coupland, C.2
Hippisley-Cox, J.3
-
46
-
-
33749618085
-
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
-
DOI 10.1056/NEJMoa061240
-
Schneider LS, Tariot PN, Dagerman KS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 2006;355:1525-38. (Pubitemid 44547805)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.15
, pp. 1525-1538
-
-
Schneider, L.S.1
Tariot, P.N.2
Dagerman, K.S.3
Davis, S.M.4
Hsiao, J.K.5
Ismail, M.S.6
Lebowitz, B.D.7
Lyketsos, C.G.8
Ryan, J.M.9
Stroup, T.S.10
Sultzer, D.L.11
Weintraub, D.12
Lieberman, J.A.13
-
48
-
-
46749128245
-
Elderly patients with dementia-related symptoms of severe agitation and aggression: Consensus statement on treatment options, clinical trials methodology, and policy
-
Salzman C, Jeste DV, Meyer RE, et al. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry 2008;69:889-98. (Pubitemid 351944940)
-
(2008)
Journal of Clinical Psychiatry
, vol.69
, Issue.6
, pp. 889-898
-
-
Salzman, C.1
Jeste, D.V.2
Meyer, R.E.3
Cohen-Mansfield, J.4
Cummings, J.5
Grossberg, G.T.6
Jarvik, L.7
Kraemer, H.C.8
Lebowitz, B.D.9
Maslow, K.10
Pollock, B.G.11
Raskind, M.12
Schultz, S.K.13
Wang, P.14
Zito, J.M.15
Zubenko, G.S.16
|